Hims & Hers Health Inc. stock surges after Novo Nordisk drops lawsuit

Name: Hims & Hers Health Inc. stock surges after Novo Nordisk drops lawsuit
Uploaded: 2026-03-09T18:20:35Z
Duration: 1 min 38 s
Description: Taylor Riggs reports on Hims & Hers Health Inc. (HIMS) stock surging 40% after Novo Nordisk dropped a patent infringement lawsuit, allowing HIMS to sell the weight loss drug Wegovy on its platform. She describes the companies' relationship as 'dramatic,' while a male panelist cautions against the stock, preferring Eli Lilly for exposure to GLP-1 drugs due to their superior pipeline.

The Big Money Show · FBN · Mar 9, 2026 · 1m 38sSign Up Now

Already a subscriber?

Taylor Riggs reports on Hims & Hers Health Inc. (HIMS) stock surging 40% after Novo Nordisk dropped a patent infringement lawsuit, allowing HIMS to sell the weight loss drug Wegovy on its platform. She describes the companies' relationship as 'dramatic,' while a male panelist cautions against the stock, preferring Eli Lilly for exposure to GLP-1 drugs due to their superior pipeline.